CYNO Cynosure - Class A (MM)

Findings from Clinical Study of Smartlipo Demonstrate Skin-Tightening Benefits of Company's Laser Lipolysis Technology WESTFORD, Mass., April 2, 2008 /PRNewswire-FirstCall/ -- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that the 28th American Society for Laser Medicine and Surgery (ASLMS) Annual Conference will include five presentations on the Company's aesthetic laser technology: Smartlipo(TM) LaserBodySculpting Workstation -- David J. Goldberg, M.D., J.D., Director of Skin Laser & Surgery Specialists of NY/NJ and Clinical Professor of Dermatology at the Mount Sinai School of Medicine in New York, will present a study that examines the benefits of the Smartlipo(TM) LaserBodySculpting workstation, Cynosure's groundbreaking flagship product for the minimally invasive removal of concentrated areas of unwanted fat. Findings of the study support the role that Smartlipo plays in the tightening of loose skin through collagen remodeling. -- Bruce Katz, M.D., Clinical Professor, Mt. Sinai School of Medicine, and Director of the Juva Skin and Laser Center in New York, will present data from a study that demonstrates a low complication rate among more than 500 patients treated with Smartlipo. "Over the past two years, we have found Smartlipo to be safe and effective with less than one percent complication rates, none of which were serious and all of which resolved over time," said Dr. Katz, who also will speak about Cynosure's laser lipolysis technology as part of a four-hour course on skin rejuvenation. "Smartlipo has become an essential and a comprehensive tool for treating unwanted fat and tightening skin." Affirm(TM) Anti-Aging Workstation -- Dr. Emil Tanghetti of the Center for Dermatology and Laser Surgery, Sacramento, Calif., and Dr. Jennifer R. Lloyd of the Lloyd Dermatology Center in Youngstown, Ohio, will present findings from a 24-patient study on their use of the Affirm Anti-Aging Workstation for the treatment of acne scars. Their research will compare the clinical benefits of Affirm's Multiplex technology, which enables the rapid sequential emission of two wavelengths, 1320 nm and 1440 nm, from the same optical fiber, to the benefits of a 1320 nm wavelength alone. -- Brian S. Biesman of the Nashville Centre for Laser and Facial Surgery in Nashville, Tenn., will discuss findings from a prospective clinical study that evaluates the benefits of the Affirm workstation from the standpoint of patient downtime and discomfort. Cynergy(TM) Vascular Workstation -- Ranella Hirsch, M.D. and Christine Dierickx, M.D. will present their evaluation of Cynosure's Cynergy Multiplex Laser for the treatment of various vascular lesions. Dr. Hirsch is Assistant Clinical Professor of Dermatology at the Boston University School of Medicine and the President of the American Society of Cosmetic Dermatology and Aesthetic Surgery. Dr. Dierickx is a Visiting Scientist at the Harvard Medical School and Director of the Skin and Laser Center in Belgium. "The scope of the data being presented at ASLMS provides further evidence of the clinical benefits of our technology for some of the aesthetic industry's fastest-growing applications," said Cynosure President and Chief Executive Officer Michael Davin. "We are privileged to have some of the industry's leading experts presenting clinical research on our technology at this conference." About ASLMS The American Society for Laser Medicine and Surgery is the world's largest scientific organization dedicated to promoting research, education and high standards of clinical care in the field of medical laser applications. It provides a forum for the exchange of scientific information and participates in communicating the latest developments in laser medicine and surgery to clinicians, research investigators, government and regulatory agencies, and the public. Founded in 1980, the Society has more than 4,000 members. About Cynosure, Inc. Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit http://www.cynosure.com/. Contact: Scott Solomon Sharon Merrill Associates, Inc. (617) 542-5300 DATASOURCE: Cynosure, Inc. CONTACT: Scott Solomon of Sharon Merrill Associates, Inc., +1-617-542-5300, , for Cynosure, Inc. Web site: http://www.cynosure.com/

Copyright